Randy Maddux
Operationeel Directeur bij iBio CDMO LLC
Actieve functies van Randy Maddux
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
iBio CDMO LLC
iBio CDMO LLC BiotechnologyHealth Technology Part of iBio, Inc., iBio CDMO LLC is a company that is advancing its immuno-oncology pipeline of antibody therapeutic candidates against hard-to-drug tumor targets. The company is based in Bryan, TX. The company uses its patented discovery platform, which leverages artificial intelligence to consistently deliver antibody candidates against difficult targets. The company's lead candidate, IBIO-101, stimulates anti-tumor immunity by selectively depleting immunosuppressive TREG cells while sparing tumor cell killing T-Effector cells. iBio is pioneering the next generation of antibody therapeutics, leveraging its artificial intelligence-based and epitope steered antibody discovery platform. The company seeks to partner IBIO-400 to develop a safe and effective subunit vaccine capable of differentiating infected from vaccinated animals. The CEO of the company is Thomas F. Isett. | Operationeel Directeur | - | - |
Loopbaan van Randy Maddux
Eerdere bekende functies van Randy Maddux
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IBIO, INC. | Operationeel Directeur | 01-12-2020 | 02-05-2022 |
GSK PLC | Corporate Officer/Principal | 01-12-2012 | 01-06-2016 |
The Life Sciences Foundation
The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services The Life Sciences Foundation engaged in education and biotechnology information dissemination. It collected and organized historical information to educate future innovators, to engage the general public, and to provide lay audiences with an understanding of life sciences and biotechnology. The company was founded by G. Steven Burrill, Dennis Gillings, John Lechleiter, Henri Termeer, and Arnold Thackray in 2010 and was headquartered in San Francisco, CA. | Directeur/Bestuurslid | - | - |
APTEVO THERAPEUTICS INC. | Operationeel Directeur | 01-07-2016 | - |
Glaxo Wellcome Plc | Corporate Officer/Principal | - | - |
BIOGEN INC. | Corporate Officer/Principal | - | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01-03-2004 | - |
Opleiding van Randy Maddux
East Carolina University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 9 |
Verenigd Koninkrijk | 3 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Operating Officer | 3 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
BIOGEN INC. | Health Technology |
APTEVO THERAPEUTICS INC. | Health Technology |
GSK PLC | Health Technology |
IBIO, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Glaxo Wellcome Plc | Health Technology |
The Life Sciences Foundation
The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services The Life Sciences Foundation engaged in education and biotechnology information dissemination. It collected and organized historical information to educate future innovators, to engage the general public, and to provide lay audiences with an understanding of life sciences and biotechnology. The company was founded by G. Steven Burrill, Dennis Gillings, John Lechleiter, Henri Termeer, and Arnold Thackray in 2010 and was headquartered in San Francisco, CA. | Commercial Services |
iBio CDMO LLC
iBio CDMO LLC BiotechnologyHealth Technology Part of iBio, Inc., iBio CDMO LLC is a company that is advancing its immuno-oncology pipeline of antibody therapeutic candidates against hard-to-drug tumor targets. The company is based in Bryan, TX. The company uses its patented discovery platform, which leverages artificial intelligence to consistently deliver antibody candidates against difficult targets. The company's lead candidate, IBIO-101, stimulates anti-tumor immunity by selectively depleting immunosuppressive TREG cells while sparing tumor cell killing T-Effector cells. iBio is pioneering the next generation of antibody therapeutics, leveraging its artificial intelligence-based and epitope steered antibody discovery platform. The company seeks to partner IBIO-400 to develop a safe and effective subunit vaccine capable of differentiating infected from vaccinated animals. The CEO of the company is Thomas F. Isett. | Health Technology |
- Beurs
- Insiders
- Randy Maddux
- Ervaring